Camp4 Therapeutics (CAMP) Shares Outstanding (Diluted Average) (2023 - 2026)

Camp4 Therapeutics has disclosed Shares Outstanding (Diluted Average) across 4 years of filings, most recently posting $57.9 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $57.9 million, up 187.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $57.9 million (up 187.42% YoY), and the FY2025 annual result was $30.4 million, up 547.76% from the prior year.
• Shares Outstanding (Diluted Average) came in at $57.9 million for Q1 2026 at Camp4 Therapeutics, up from $30.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $57.9 million in Q1 2026 to a low of $383653.0 in Q3 2023.
• The 4-year median for Shares Outstanding (Diluted Average) is $4.7 million (2024), against an average of $14.8 million.
• Across the five-year window, Shares Outstanding (Diluted Average) surged 31.23% in 2024 and soared 5317.51% in 2025, its largest moves.
• Camp4 Therapeutics' Shares Outstanding (Diluted Average) stood at $394976.0 in 2023, then soared by 1087.44% to $4.7 million in 2024, then jumped by 547.76% to $30.4 million in 2025, then surged by 90.66% to $57.9 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $57.9 million (Q1 2026), $30.4 million (Q4 2025), and $27.3 million (Q3 2025), per Business Quant data.